The Allstate Co. (NYSE:ALL) Shares Bought by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. grew its holdings in The Allstate Co. (NYSE:ALL) by 55.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 22,596 shares of the insurance provider’s stock after buying an additional 8,046 shares during the period. Crossmark Global Holdings Inc.’s holdings in Allstate were worth $4,356,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Pathway Financial Advisers LLC grew its position in Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after purchasing an additional 1,047,019 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after buying an additional 472,040 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Allstate by 181.6% in the 2nd quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock valued at $114,955,000 after acquiring an additional 464,337 shares during the period. TimesSquare Capital Management LLC purchased a new position in Allstate in the 3rd quarter worth $77,819,000. Finally, Los Angeles Capital Management LLC lifted its position in Allstate by 688.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider’s stock worth $87,292,000 after acquiring an additional 401,901 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Stock Performance

NYSE:ALL opened at $185.05 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market capitalization of $49.00 billion, a PE ratio of 11.98, a P/E/G ratio of 1.42 and a beta of 0.52. The Allstate Co. has a fifty-two week low of $153.42 and a fifty-two week high of $209.88. The company has a fifty day moving average of $195.39 and a two-hundred day moving average of $187.12.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same period last year, the company posted $0.81 EPS. Allstate’s quarterly revenue was up 14.7% compared to the same quarter last year. As a group, research analysts forecast that The Allstate Co. will post 16.72 earnings per share for the current fiscal year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 1.99%. The ex-dividend date was Friday, November 29th. Allstate’s payout ratio is 23.83%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on ALL shares. UBS Group increased their price objective on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Morgan Stanley raised their price target on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. Bank of America upped their price objective on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a report on Friday, October 18th. BMO Capital Markets raised their target price on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Finally, Keefe, Bruyette & Woods upped their price target on shares of Allstate from $235.00 to $243.00 and gave the company an “outperform” rating in a report on Friday, January 10th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $218.13.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.